CoChat

PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms

Open access
Li, Xiao-Lan, Zhou, Jianbiao, Chan, Zit-Liang, Chooi, Jing-Yuan, Chen, Zhi-Rong, Chng, Wee-Joo · 2015 · Oncotarget
Cited by 48

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

// Xiao-Lan Li 1, 2, * , Jianbiao Zhou 1, * , Zit-Liang Chan 1 , Jing-Yuan Chooi 1 , Zhi-Rong Chen 2 , Wee-Joo Chng 1, 3, 4 1 Cancer Science Institute of Singapore, National University of Singapore, Centre for Translational Medicine, Singapore 117599, Republic of Singapore 2 Department of Gastroenterology, Suzhou Municipal Hospital (Eastern), Suzhou City, Jiangsu Province, 215001, P.R. China 3 Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Republic of Singapore 4 Department of Hematology-Oncology, National University Hospital, Singapore 119228, Republic of Singapore * These authors have contributed equally to this work Correspondence to: Wee-Joo Chng, e-mail: mdccwj@nus.edu.sg Zhi-Rong Chen, e-mail: czr88188@163.com Keywords: colorectal cancer (CRC), p53, tumor suppressor gene (TSG), PRIMA-1 met , targeted therapy Received: July 14, 2015 Accepted: September 17, 2015 Published: October 01, 2015 ABSTRACT PRIMA-1 met (APR-246) is a methylated derivative and structural analog of PRIMA-1 (p53 re-activation and induction of massive apoptosis). PRIMA-1 met has been reported to restore both the wild type (wt) structure and function of mutant p53. Here, we show that PRIMA-1 met is highly effective at limiting the growth of CRC cells regardless of p53 status. However, PRIMA-1 met induces robust apoptosis only in CRC cells with mutant p53. Upregulation of Noxa, a proapoptotic molecule, is crucial for PRIMA-1 met mediated activity. In human xenograft model of disease, PRIMA-1 met effectively suppresses CRC tumor growth. Our results uncover distinct mechanisms of PRIMA-1 met in CRC with different p53 status, thus providing a mechanistic rationale to evaluate the clinical efficacy of PRIMA-1 met in CRC patients with different p53 status.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.5385

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 48

Metadata

Authors
Li, X.-L., Zhou, J., Chan, Z.-L., Chooi, J.-Y., Chen, Z.-R., & Chng, W.-J.
Venue
Oncotarget
Published
2015-10-01
Volume
6
Issue
34
Pages
36689-36699
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1893278446
Cited by
48
References
4
FWCI
1.56
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.